Global Analgesics Market to Reach US$ 77.2 Billion by 2032, Impelled by the Increasing Prevalence of Chronic and Lifestyle Diseases

May 04, 2022 | Healthcare

According to the latest report by IMARC Group, titled "Analgesics Market Report by Type (Prescription, Over-The-Counter (OTC)), Drug Class (Opioids, NSAIDs, and Others), Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal), Pain Type (Musculoskeletal, Surgical and Trauma, Cancer, Neuropathic, Migraine, Obstetrical, Fibromyalgia, Pain due to Burns, Dental/Facial, Pediatric, and Others), Application (Internal, External), and Region 2024-2032," the global analgesics market reached a value of US$ 54.1 Billion in 2023. Analgesics refers to a class of drugs that help relieve pain without blocking nerve impulse conduction, affecting consciousness or altering sensory perception. They function by limiting the transmission of pain signals to the brain and interfering with its ability to interpret those signals. Derived from salicylic acid and phenacetin, some common analgesics include acetaminophen, aspirin, paracetamol, COX inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioid drugs. They are widely used to treat post-operative pain, inflammation, menstrual cramps, neuropathic conditions, headache, cancer treatment, and injuries, such as fractured bones.

Global Analgesics Market Trends:

The growing demand for pain management therapeutics, such as analgesics, across the globe can be attributed to the increasing prevalence of various chronic and lifestyle disorders, including cardiovascular disease, cancer, toothache, headache, sore muscles and arthritis, particularly among the rising geriatric population. They are widely used to treat moderate to acute pain associated with these medical conditions, which, in turn, is driving the market growth. Apart from this, various product innovations, such as the development of safer opioids with immediate and effective pain relief and enhanced efficacy and fewer side effects, are providing a considerable boost to the market growth. Additionally, various pharmaceutical companies are collaborating with e-commerce platforms to enable the delivery of analgesics and other drugs to the doorstep of consumers, especially during the global outbreak of the coronavirus disease (COVID-19) pandemic and the consequent imposition of mandatory lockdowns, which, in turn, is contributing to the market growth. Other factors, including extensive research and development (R&D) activities to engineer novel combinations of the drug and the implementation of various government initiatives to increase awareness regarding effective pain management, are anticipated to drive the market toward growth. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 77.2 Billion by 2032, growing at a CAGR of 3.9% during 2024-2032.

Market Summary:

  • On the basis of the type, the market has been bifurcated into prescription and over the counter (OTC). Prescription analgesics currently represent the most popular drug type across the globe.
  • Based on the drug class, the market has been divided into opioids, NSAID and others. Presently, opioids dominate the market.
  • On the basis of the route of administration, the market has been classified into oral, parenteral, topical, transdermal, and rectal. Amongst these, oral is the most common route of administration (ROA).
  • Based on the pain type, the market has been classified into musculoskeletal, surgical and trauma, cancer, neuropathic, migraine, obstetrical, fibromyalgia, pain due to burns, dental/facial, pediatric, and others. At present, musculoskeletal pain accounts for the majority of the global market share.
  • On the basis of the application, the market has been bifurcated into internal and external.
  • Based on region, the market has been categorized into North America, Asia-Pacific, Europe, Latin America and Middle East and Africa. On the geographical front, North America enjoys the leading position in the market.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of these players include Bayer AG, Novartis International AG, GlaxoSmithKline PLC, Pfizer Inc., Johnson & Johnson Pvt. Ltd., Reckitt Benckiser (RB) Group PLC, Endo Pharmaceuticals PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, Sanofi SA, etc.


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:


USA: +1-631-791-1145
Follow us on twitter : @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Analgesics Market to Reach US$ 77.2 Billion by 2032, Impelled by the Increasing Prevalence of Chronic and Lifestyle Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More